CORDIS - Forschungsergebnisse der EU
CORDIS

Deciphering the ubiquitin code of the TNF receptor signalling complex and its functional role in inflammation and immunity

Ziel

Tumour necrosis factor (TNF) is a cytokine with important functions in inflammation, immunity and cancer. Signalling processes mediated by ubiquitin are crucial for TNF signalling. The seven lysine (K) residues and the N-terminus of ubiquitin can be used to form ubiquitin chains. Employing a method newly developed in our laboratory we identified the presence of four of these ubiquitin chain linkage types in the native TNF receptor signalling complex (TNF-RSC). Our knowledge of the specific functions of the different ubiquitin linkages is currently very limited. However, their presence in the TNF-RSC, combined with our recent technological advance in dissecting the composition of this protein complex with previously unreached specificity and sensitivity provides a unique opportunity for the proposed research programme: to molecularly and functionally decipher the ubiquitin code. We will aim to achieve this by studying the different ubiquitin chain linkages at the molecular level within the TNF-RSC and by determining how perturbation of specific ubiquitin linkage events impacts the physiological role of TNF in immunity to infection and its pathological function in inflammation-induced cancer.
The specific objectives of this project are:
• to molecularly decipher the ubiquitin code of the TNF-RSC (objective 1),
• to link this code to physiological functions of TNF in immunity to infection (objective 2)
• and to test its pathological impact on cancer-related inflammation (objective 3).

Aufforderung zur Vorschlagseinreichung

ERC-2011-ADG_20110310
Andere Projekte für diesen Aufruf anzeigen

Gastgebende Einrichtung

UNIVERSITY COLLEGE LONDON
EU-Beitrag
€ 1 760 601,26
Adresse
GOWER STREET
WC1E 6BT LONDON

Auf der Karte ansehen

Aktivitätstyp
Higher or Secondary Education Establishments
Hauptforscher
Henning Walczak (Prof.)
Kontakt Verwaltung
Giles Machell (Mr.)
Links
Gesamtkosten
Keine Daten

Begünstigte (2)